Pancreatectomy with major arterial resection after neoadjuvant chemoradiotherapy gemcitabine and S-1 and concurrent radiotherapy for locally advanced unresectable pancreatic cancer
- 1 July 2015
- journal article
- Published by Elsevier BV in Surgery
- Vol. 158 (1), 191-200
- https://doi.org/10.1016/j.surg.2015.02.016
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- A multi‐institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancerCancer, 2013
- Surgical strategy for patients with pancreatic body/tail carcinoma: Who should undergo distal pancreatectomy with en-bloc celiac axis resection?Surgery, 2013
- Japan Pancreatic Cancer Registry; 30th Year AnniversaryPancreas, 2012
- Pathological and clinical impact of neoadjuvant chemoradiotherapy using full‐dose gemcitabine and concurrent radiation for resectable pancreatic cancerJournal of Hepato-Biliary-Pancreatic Sciences, 2012
- Is celiac axis resection justified for T4 pancreatic body cancer?Surgery, 2012
- Arterial en bloc resection for pancreatic carcinomaBritish Journal of Surgery, 2010
- Distal Pancreatectomy With En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Body CancerAnnals of Surgery, 2007
- A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic CarcinomaAnnals of Surgical Oncology, 2006
- Pancreatic Cancer Registry in JapanPancreas, 2004
- Preoperative Chemoradiation for Patients With Pancreatic Cancer: Toxicity of Endobiliary StentsJournal of Clinical Oncology, 2000